| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/18/2008 | WO2008031831A3 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| 09/18/2008 | WO2007104933A8 Chemical compounds |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof |
| 09/18/2008 | US20080227860 Composition Comprising Oleic Acid and the Use Thereof |
| 09/18/2008 | US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 09/18/2008 | US20080227843 Therapeutic use of n-(1h-indolyl)-1h-indole-2-carboxamide derivatives |
| 09/18/2008 | US20080227837 Novel Compounds |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227829 for stimulating neurogenesis, including in vitro neurogenesis, by contacting neuronal progenitor cells with an effective amount of the compound(s) described herein; apigenin; acacetin; luteolin |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227824 5-(Phenylisoxazolylethoxy) - Triazol- 3 -Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders |
| 09/18/2008 | US20080227818 Neurokinin A receptor antagonist |
| 09/18/2008 | US20080227816 Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases |
| 09/18/2008 | US20080227815 Crystal of Indole Derivative Having Piperidine Ring and Process for Production Thereof |
| 09/18/2008 | US20080227813 Mixture of a C-disubstituted-O-substituted oxime, e.g., N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride another drug (riluzole), and a carrier; treating amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's Disease, stroke and cystic fibrosis. |
| 09/18/2008 | US20080227806 prodrug is a dihydrotrigoneline CDS moiety coupled to an epoxysuccinyl peptide cysteine protease inhibitor moiety; Alzheimer's disease and vascular dementia |
| 09/18/2008 | US20080227803 relieving and/or preventing side effects induced by a compound having opioid receptor agonism |
| 09/18/2008 | US20080227794 Metabotropic Glutamate-Receptor-Potentiating Isoindolones |
| 09/18/2008 | US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement |
| 09/18/2008 | US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride |
| 09/18/2008 | US20080227783 5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors |
| 09/18/2008 | US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders |
| 09/18/2008 | US20080227777 Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1 |
| 09/18/2008 | US20080227776 inhibiting heme-induced lipid peroxidation; preventing isoprostane-mediated tissue damage |
| 09/18/2008 | US20080227773 N-[4-(1,4-Diaza-bicyclo[3.2.2]non-4-yl)-phenyl]-benzamide; disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse |
| 09/18/2008 | US20080227772 Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands |
| 09/18/2008 | US20080227770 Benzoxazepine Compound |
| 09/18/2008 | US20080227767 Methods and compounds for inhibiting amyloid deposits |
| 09/18/2008 | US20080227764 E.g., 3,-30-pregnanediones or 11,20-pregnanedioles; optionally in association with one or more other analgesic compounds such as opioids; does not result in overt sedation |
| 09/18/2008 | US20080227760 Using gradient salting-out instead of conventional silica gel chromatography enables convenient performance and mass production; preventing and treating dementia, depression, and peripheral circulation disorder |
| 09/18/2008 | US20080227736 Used to transduce heterologous genes into a cell and can be used for in vivo and ex vivo therapeutic applications, as well as for diagnostic and research tool applications |
| 09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227699 Therapeutic Agent for Neurodegenerative Diseases |
| 09/18/2008 | US20080227684 Small Molecule Inhibitors of PDZ Interactions |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080226719 Therapy, prophylaxis Alzheimer's disease |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226715 Therapeutic compositions and methods |
| 09/18/2008 | US20080226696 Administerign dosage of carnitine and lipoc acid |
| 09/18/2008 | US20080226695 Water degradation; controlled drying; self-supporting edible film; uniform distribution; mixing water soluble polymer with water and active material; deaeration |
| 09/18/2008 | US20080226650 Cotinine neutralizing antibody |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226639 Heparin Binding Peptide |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226615 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 09/18/2008 | US20080226612 Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
| 09/18/2008 | US20080226609 Transplantation of Glial Restricted Precursor-Derived Astrocytes for Promotion of Axon Growth |
| 09/18/2008 | US20080226583 Therapeutic polyesters and polyamides |
| 09/18/2008 | US20080226559 Benztropine Compounds and Uses Thereof |
| 09/18/2008 | DE102007012165A1 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes Use of 1-phenyl-3-dimethylaminopropane compounds for the therapy of neuropathy pain |
| 09/18/2008 | DE102007009235A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives |
| 09/18/2008 | CA2681118A1 Amide derivatives as calcium channel blockers |
| 09/18/2008 | CA2680938A1 Novel preventive and/or therapeutic agent for diabetic neuropathy |
| 09/18/2008 | CA2680935A1 Novel preventive and/or therapeutic agent for neuropathic pain |
| 09/18/2008 | CA2680525A1 Nitroxide radical as a treatment for neurodegeneration |
| 09/18/2008 | CA2680272A1 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia |
| 09/18/2008 | CA2679884A1 Aminopyrimidines useful as inhibitors of protein kinases |
| 09/18/2008 | CA2679701A1 Aminopyridines useful as inhibitors of protein kinases |
| 09/18/2008 | CA2678897A1 Dibenzo[b,f][1,4]oxazapine compounds |
| 09/18/2008 | CA2677713A1 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 09/17/2008 | EP1970438A1 Pasteurisation process for microbial cells and microbial oil |
| 09/17/2008 | EP1970386A2 Hybrid immunoglobulins |
| 09/17/2008 | EP1970383A1 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 09/17/2008 | EP1970370A1 Amorphous form of 1,2-dihydropyridine compound |
| 09/17/2008 | EP1970070A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/17/2008 | EP1970060A2 Use of C-(2-Phenyl-cyclohexyl)-methylamine compounds for fibromyalgia therapy |
| 09/17/2008 | EP1970055A2 Multi-layered tablet with triple release combination |
| 09/17/2008 | EP1970050A1 Intravenous emulsion of butylbenzene phthalein and its application |
| 09/17/2008 | EP1968978A2 Forms of dolasetron mesylate and processes for their preparation |
| 09/17/2008 | EP1968977A1 Aryl-isoxazol-4-yl-imidazoý1, 5-a¨pyridine derivatives |
| 09/17/2008 | EP1968972A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 09/17/2008 | EP1968968A1 Compositions and methods for modulating gated ion channels |
| 09/17/2008 | EP1968958A1 Substituted thiazoles and their use for producing drugs |
| 09/17/2008 | EP1968956A2 Calcium channel antagonists |
| 09/17/2008 | EP1968954A1 Macrocyclic compounds useful as bace inhibitors |
| 09/17/2008 | EP1968944A1 Alkylsulphonamide quinolines |
| 09/17/2008 | EP1968938A1 Substituted propiolic acid amides and their use for producing drugs |
| 09/17/2008 | EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 09/17/2008 | EP1968591A2 Treatment of synucleinopathies |
| 09/17/2008 | EP1968588A2 Crystalline forms of dolasetron base and processes for preparation thereof |
| 09/17/2008 | EP1968583A2 Compounds, screens, and methods of treatment |
| 09/17/2008 | EP1968576A1 Mif inhibitors |
| 09/17/2008 | EP1968573A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 09/17/2008 | EP1968572A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 09/17/2008 | EP1968571A2 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 09/17/2008 | EP1968567A1 Omega 3 fatty acid formulations |
| 09/17/2008 | EP1968563A2 Treatment methods using triaryl methane compounds |
| 09/17/2008 | EP1732892B1 Tetrahydrocarbazoles and derivatives |
| 09/17/2008 | EP1503790B1 Intracranial treatment of neuropsychiatric disorders by clostridial neurotoxins such as botulinum toxin |
| 09/17/2008 | EP1495003B1 Fredericamycin derivatives |
| 09/17/2008 | EP1490067B1 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 09/17/2008 | EP1463525B1 Compositions and methods for the diagnosis and treatment of tumor |
| 09/17/2008 | EP1447400B1 Bicyclic compound |
| 09/17/2008 | EP1446383B1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 09/17/2008 | EP1414947B1 Multipotent stem cells from peripheral tissues and uses thereof |